GO
Loading...

Ariad CEO talks Iclusig trials

Monday, 2 Jun 2014 | 12:34 PM ET

Ariad Pharmaceuticals CEO Dr. Harvey Berger, says investors are responding to his company's better overall picture, and the progress on its leukemia drug Iclusig.